Arlene Buller

786 total citations
27 papers, 453 citations indexed

About

Arlene Buller is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Arlene Buller has authored 27 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 8 papers in Genetics. Recurrent topics in Arlene Buller's work include Cystic Fibrosis Research Advances (10 papers), Congenital Ear and Nasal Anomalies (6 papers) and Tracheal and airway disorders (5 papers). Arlene Buller is often cited by papers focused on Cystic Fibrosis Research Advances (10 papers), Congenital Ear and Nasal Anomalies (6 papers) and Tracheal and airway disorders (5 papers). Arlene Buller collaborates with scholars based in United States, Poland and Canada. Arlene Buller's co-authors include Weimin Sun, Joy B. Redman, Charles M. Strom, Franklin Quan, Beryl Crossley, Matthew J. McGinniss, Mei Peng, Ben Anderson, Donghui Huang and Charles M. Strom and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Human Genetics.

In The Last Decade

Arlene Buller

27 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arlene Buller United States 14 192 154 138 82 40 27 453
Caroline Guittard France 16 420 2.2× 106 0.7× 118 0.9× 108 1.3× 41 1.0× 27 587
Silvia Spena Italy 13 178 0.9× 185 1.2× 117 0.8× 45 0.5× 16 0.4× 25 527
Özgül M. Alper Türkiye 13 118 0.6× 160 1.0× 134 1.0× 54 0.7× 20 0.5× 35 472
Anna L. Mitchell United States 14 127 0.7× 176 1.1× 324 2.3× 32 0.4× 16 0.4× 24 535
Kevin Iori United States 7 129 0.7× 354 2.3× 155 1.1× 51 0.6× 15 0.4× 8 579
Loredana Moi Italy 12 36 0.2× 247 1.6× 155 1.1× 147 1.8× 57 1.4× 23 512
Jean P. Pfotenhauer United States 8 87 0.5× 211 1.4× 156 1.1× 16 0.2× 20 0.5× 9 438
Ayala Aviram Israel 8 26 0.1× 168 1.1× 161 1.2× 75 0.9× 38 0.9× 9 328
Keisuke Sugimoto Japan 10 48 0.3× 108 0.7× 59 0.4× 42 0.5× 46 1.1× 64 353
Jodi D. Hoffman United States 18 74 0.4× 215 1.4× 365 2.6× 41 0.5× 67 1.7× 33 654

Countries citing papers authored by Arlene Buller

Since Specialization
Citations

This map shows the geographic impact of Arlene Buller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arlene Buller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arlene Buller more than expected).

Fields of papers citing papers by Arlene Buller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arlene Buller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arlene Buller. The network helps show where Arlene Buller may publish in the future.

Co-authorship network of co-authors of Arlene Buller

This figure shows the co-authorship network connecting the top 25 collaborators of Arlene Buller. A scholar is included among the top collaborators of Arlene Buller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arlene Buller. Arlene Buller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kalman, Lisa V., Jean Amos Wilson, Arlene Buller, et al.. (2009). Development of Genomic DNA Reference Materials for Genetic Testing of Disorders Common in People of Ashkenazi Jewish Descent. Journal of Molecular Diagnostics. 11(6). 530–536. 7 indexed citations
2.
Pratt, Victoria M., Michele Caggana, Arlene Buller, et al.. (2009). Development of Genomic Reference Materials for Cystic Fibrosis Genetic Testing. Journal of Molecular Diagnostics. 11(3). 186–193. 27 indexed citations
3.
Mikula, Mario, Arlene Buller, Weimin Sun, & Charles M. Strom. (2008). Prevalence of known mutations in the familial Mediterranean fever gene (MEFV) in various carrier screening populations. Genetics in Medicine. 10(5). 349–352. 11 indexed citations
4.
Kalman, Lisa V., Monique Johnson, Jeanne C. Beck, et al.. (2007). Development of genomic reference materials for Huntington disease genetic testing. Genetics in Medicine. 9(10). 719–723. 16 indexed citations
5.
Strom, Charles M., Beryl Crossley, Joy B. Redman, et al.. (2007). Molecular testing for Fragile X Syndrome: Lessons learned from 119,232 tests performed in a clinical laboratory. Genetics in Medicine. 9(1). 46–51. 42 indexed citations
6.
Hantash, Feras, Joy B. Redman, Ben Anderson, et al.. (2006). Novel and recurrent rearrangements in the CFTR gene: clinical and laboratory implications for cystic fibrosis screening. Human Genetics. 119(3). 352–352. 1 indexed citations
7.
Sun, Weimin, Ben Anderson, Joy B. Redman, et al.. (2006). CFTR 5T variant has a low penetrance in females that is partially attributable to its haplotype. Genetics in Medicine. 8(6). 339–345. 22 indexed citations
8.
9.
Brown, Nicholas M., Victoria M. Pratt, Arlene Buller, et al.. (2005). Detection of 677CT/1298AC “double variant” chromosomes: Implications for interpretation of MTHFR genotyping results. Genetics in Medicine. 7(4). 278–282. 16 indexed citations
10.
McGinniss, Matthew J., Christina Chen, Joy B. Redman, et al.. (2005). Extensive Sequencing of the CFTR gene: lessons learned from the first 157 patient samples. Human Genetics. 118(3-4). 331–338. 25 indexed citations
11.
Hantash, Feras, Joy B. Redman, Ben Anderson, et al.. (2005). Novel and recurrent rearrangements in the CFTR gene: clinical and laboratory implications for cystic fibrosis screening. Human Genetics. 119(1-2). 126–136. 37 indexed citations
12.
Strom, Charles M., Richard Janeczko, Ben Anderson, et al.. (2005). Technical validation of a multiplex platform to detect thirty mutations in eight genetic diseases prevalent in individuals of Ashkenazi Jewish descent. Genetics in Medicine. 7(9). 633–639. 13 indexed citations
13.
Strom, Charles M., Beryl Crossley, Joy B. Redman, et al.. (2004). Cystic fibrosis screening: Lessons learned from the first 320,000 patients. Genetics in Medicine. 6(3). 136–140. 24 indexed citations
14.
Buller, Arlene, Susan C. Olson, Joy B. Redman, et al.. (2004). Frequency of the cystic fibrosis 3199del6 mutation in individuals heterozygous for I148T. Genetics in Medicine. 6(2). 108–109. 11 indexed citations
15.
Strom, Charles M., Beryl Crossley, Joy B. Redman, et al.. (2004). Molecular screening for diseases frequent in Ashkenazi Jews: Lessons learned from more than 100,000 tests performed in a commercial laboratory. Genetics in Medicine. 6(3). 145–152. 28 indexed citations
16.
Strom, Charles M., Donghui Huang, Arlene Buller, et al.. (2002). Cystic fibrosis screening using the College panel: Platform comparison and lessons learned from the first 20,000 samples. Genetics in Medicine. 4(4). 289–296. 42 indexed citations
17.
Barcus, Mary E., Andrea Ferreira‐Gonzalez, Arlene Buller, David S. Wilkinson, & Carleton T. Garrett. (2000). Genetic changes in solid tumors. Seminars in Surgical Oncology. 18(4). 358–370. 1 indexed citations
18.
Buller, Arlene. (2000). Validation of a multiplex methylation-sensitive PCR assay for the diagnosis of Prader-Willi and Angelman's syndromes. Molecular Diagnosis. 5(3). 239–243. 10 indexed citations
19.
Buller, Arlene, et al.. (1999). A Combination of Hydroxyurea and Isobutyramide to Induce Fetal Hemoglobin in Transgenic Mice Is More Hematotoxic Than the Individual Agents. Blood Cells Molecules and Diseases. 25(4). 255–269. 5 indexed citations
20.
Buller, Arlene, et al.. (1999). The gamma-Globin Promoter Has a Major Role in Competitive Inhibition of beta-Globin Gene Expression in Early Erythroid Development. DNA and Cell Biology. 18(4). 293–303. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caroline Guittard Breakdown of academic impact, for papers by Silvia Spena Breakdown of academic impact, for papers by Özgül M. Alper Breakdown of academic impact, for papers by Anna L. Mitchell Breakdown of academic impact, for papers by Kevin Iori Breakdown of academic impact, for papers by Loredana Moi Breakdown of academic impact, for papers by Jean P. Pfotenhauer Breakdown of academic impact, for papers by Ayala Aviram Breakdown of academic impact, for papers by Keisuke Sugimoto Breakdown of academic impact, for papers by Jodi D. Hoffman
Rankless by CCL
2026